Rick Doblin reflects on 38 years of MAPS, discussing psychedelic milestones and obstacles. Lykos Therapeutics submits NDA for MDMA-assisted therapy for PTSD in December 2023.
Rick Doblin
Judith Herman's insights on integrating psychedelic therapy with mindfulness to protect against harm from current systems are discussed in this exploration of trauma and healing.
Bruce Poulter, Marcela Ot’alora
MDMA optimizes brain chemistry for safety, openness, and compassion. AEDP uses relational interventions to enhance MDMA's effects in trauma therapy, fostering trust, intimacy, and healing attachment.
Kari Gleiser
Speaker discusses underlying assumptions of psychedelic therapy and therapist's role, emphasizing presence in facilitating healing. Draws from personal experiences with MDMA, psilocybin, and ketamine research volunteers.
Norma Stevens
Dr. Alexander Shulgin was a prolific psychedelic researcher, known as the "Godfather of Psychedelics". Drs. Paul Daley and Nicholas Cozzi now lead the Alexander Shulgin Research Institute in creating new,
Rave culture and electronic music are modern forms of ritual that tap into primal instincts, offering potential for social bonding, trauma processing, and expanded awareness through movement and psychedelics.
Taylor Bratches
Dr. Barbara Rothbaum discusses combining MDMA with prolonged exposure therapy for PTSD, citing theoretical and translational research supporting a synergistic mechanism of action for treatment.
Barbara Rothbaum, Lynnette A. Averill
Dr. Ben Sessa will discuss similarities among MDMA, ketamine, and psilocybin in clinical settings, exploring their potential in treating trauma-based disorders and challenges in psychedelic medicalization.
Ben Sessa
MDMA's therapeutic mechanism differs from classical psychedelics, showing potential for treating CNS disorders. Shulgin's 1970s research inspired exploration of modifying MDMA's structure and developing novel compounds for improved effects.
Matthew Baggott
Dr. Zeifman, Dr. Traynor, and Dr. Roberts explore the potential of psychedelic-assisted psychotherapy for Borderline Personality Disorder, discussing observational studies, promising research, and upcoming clinical trials in this symposium.
Daniel E Roberts, Jenna Traynor, Richard Zeifman
© 1986 – 2025 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mailing: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.